Published in
Elsevier, Multiple Sclerosis and Related Disorders, (46), p. 102543, 2020
DOI: 10.1016/j.msard.2020.102543
Links
Tools
Long-term effectiveness of natalizumab on MRI outcomes and no evidence of disease activity in relapsing-remitting multiple sclerosis patients treated in a Czech Republic real-world setting: a longitudinal, retrospective study
Journal article published in 2020 by
Dana Horakova 
,
Tomas Uher ,
Jan Krasensky,
Zdeněk Seidl,
Annemie Ribbens,
Wim Van Hecke,
Thibo Billiet,
Harold Koendgen,
Ulrich Freudensprung,
Robert Hyde,
Manuela Vaneckova
,
Tomas Uher ,
Jan Krasensky,
Zdeněk Seidl,
Annemie Ribbens,
Wim Van Hecke,
Thibo Billiet,
Harold Koendgen,
Ulrich Freudensprung,
Robert Hyde,
Manuela Vaneckova
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 